Browsing William Harvey Research Institute by Title
Now showing items 3558-3577 of 4583
-
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration.
(Wiley, 2024-10-20)BACKGROUND AND PURPOSE: Angiogenesis is a pathological component of neovascular age-related macular degeneration. Current therapies, although successful, are prone to high levels of patient non-response and a loss of ... -
QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction
(2024-12-01)Postnatal growth failure is often attributed to dysregulated somatotropin action, however marked genetic and phenotypic heterogeneity exist. We report five patients from three families who present with short stature, immune ... -
Quality Control-Driven Image Segmentation Towards Reliable Automatic Image Analysis in Large-Scale Cardiovascular Magnetic Resonance Aortic Cine Imaging
(Springer, Cham, 2019-10-10)© 2019, Springer Nature Switzerland AG. Recent progress in fully-automated image segmentation has enabled efficient extraction of clinical parameters in large-scale clinical imaging studies, reducing laborious manual ... -
Quality of life in patients with adrenal disease: A systematic review.
(2018-04-19)BACKGROUND: Evaluating the patient with adrenal disease is challenging due to the lack of precise clinical and biochemical parameters for disease control. Quality of life (QOL) evaluation aims to measure the patient's ... -
Quantifying stochasticity in the aging DNA methylome.
(Nature Research, 2024-05-16)Aging-related DNA methylation changes are numerous. Their precise measurement has opened new avenues to explore aging-related disease pathology, including the construction of chronological and biological age predictors ... -
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
(Sage Publications, 2014-09-19)There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this ... -
Quantitative flow ratio to predict non-target-vessel-related events at 5 years in STEMI patients undergoing angiography-guided revascularization
(Oxford University Press (OUP), 2020-11-01) -
Quantitative Flow Ratio to Predict Nontarget Vessel-Related Events at 5 Years in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Angiography-Guided Revascularization.
(2021-05-04)Background In ST-segment-elevation myocardial infarction, angiography-based complete revascularization is superior to culprit-lesion-only percutaneous coronary intervention. Quantitative flow ratio (QFR) is a novel, ... -
RA SYNOVIAL RECOMBINANT MONOCLONAL ANTIBODIES FROM SINGLE B CELLS TARGET CITRULLINATED CALRETICULIN
(2017-03-01)Meeting abstract 08.34 from 37th European Workshop on Rheumatology Research (EWRR) Athens, GREECE, MAR 02-04, 2017